Smart Technology for Weight Loss and Metabolic Health

Sponsor
Temple University (Other)
Overall Status
Completed
CT.gov ID
NCT02742662
Collaborator
The Obesity Treatment Foundation (Other)
29
1
2
19
1.5

Study Details

Study Description

Brief Summary

The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their diet and activity via smartphone applications as compared with conventional in-person weight management programs.

Condition or Disease Intervention/Treatment Phase
  • Device: Wearable technology, smartscale
  • Behavioral: Smartphone applications
  • Behavioral: Standard Weight Management Visits
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
29 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Smart Technology for Weight Loss and Metabolic Health- A Randomized Controlled Trial
Study Start Date :
Apr 1, 2016
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Nov 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Smart Technology Group

The Smart Technology Group will receive a technology-based lifestyle intervention program which uses wearable technology, smartscales and smartphone applications to track and deliver feedback on caloric expenditure, physical activity, caloric intake and body weight. Participants will receive information through smartphone applications on strategies to make changes to their diet, physical activity, and weight-related behaviors along with standard 3 monthly in-person weight management visits.

Device: Wearable technology, smartscale

Behavioral: Smartphone applications

Behavioral: Standard Weight Management Visits

Other: Standard Weight Management Group

The Standard Weight Management Group will receive 3 monthly in-person weight management visits during which they will receive standard of care lifestyle recommendations in accordance with the 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline.

Behavioral: Standard Weight Management Visits

Outcome Measures

Primary Outcome Measures

  1. Change in body weight in kg [6 months]

Secondary Outcome Measures

  1. Change from baseline blood pressure [6 months]

  2. Change from baseline waist circumference [6 months]

  3. Change from baseline insulin resistance by homeostasis model assessment (HOMA-IR) [6 months]

  4. Change from baseline hemoglobin A1c [6 months]

  5. Change from baseline plasma triglycerides [6 months]

  6. Change from baseline body weight in kg [3 months]

  7. Change from baseline body weight in kg [12 months]

  8. Change from baseline blood pressure [12 months]

  9. Change from baseline waist circumference [12 months]

  10. Change in Quality of Life [6 months after receiving the intervention]

    SF36 Questionnaire in wait-listed control group after the intervention

  11. Change in insulin resistance by homeostasis model assessment (HOMA-IR) [12 months compared to baseline and 6 months after receiving the intervention]

    Wait-listed control group

  12. Change in hemoglobin A1c [12 months compared to baseline and 6 months after receiving the intervention and from baseline]

    Wait-listed control group

  13. Change in plasma triglycerides [12 months compared to baseline and 6 months after receiving the intervention]

    Wait-listed control group

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Overweight or obese BMI 25-42 kg/m2

  • Employed in sedentary occupations

  • Own a personal smartphone with unlimited data plan or >4 GigaByte data

  • Proficient with use of smartphone applications and technology with current daily usage

  • Ability to engage in moderate intensity exercise

  • Weight stability for the last 2 months

  • Participants must be willing to comply with all study-related procedures

Exclusion Criteria:
  • Current or planned pregnancy

  • Cardiovascular, pulmonary, renal disease, joint disease

  • Uncontrolled thyroid disease

  • History of eating disorders, psychiatric disease

  • History of substance abuse or dependence in the last 1 year

  • Diabetes

  • Shift work

  • Previous weight loss surgery

  • Use of weight loss drugs/diet/program in the last 6 weeks

  • Inability to increase walking as a form of exercise and to engage in moderate intensity exercise

  • Other conditions or medications that affect body weight/appetite/metabolism

  • Serious or unstable medical or psychological conditions that would compromise the subject's safety for successful participation

  • Incapable of adhering with an intensive lifestyle intervention using technology and smartphone applications

Contacts and Locations

Locations

Site City State Country Postal Code
1 Temple University Philadelphia Pennsylvania United States 19140

Sponsors and Collaborators

  • Temple University
  • The Obesity Treatment Foundation

Investigators

  • Principal Investigator: Cherie Vaz, MD Dipl ABOM, Temple University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Temple University
ClinicalTrials.gov Identifier:
NCT02742662
Other Study ID Numbers:
  • 23217
First Posted:
Apr 19, 2016
Last Update Posted:
Feb 15, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Temple University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2018